Perspectives and important needs in parasite chemotherapy.
D000871:Anthelmintics / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000494:pharmacology*; D000981:Antiprotozoal Agents / Q000494:pharmacology; D014355:Chagas Disease / Q000188:drug therapy; D003551:Cysticercosis / Q000188:drug therapy; D004345:Drug Industry; D004358:Drug Therapy; D004443:Echinococcosis / Q000188:drug therapy; D004463:Ecology; D005211:Fascioliasis / Q000188:drug therapy; D005368:Filariasis / Q000188:drug therapy; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy; D008288:Malaria / Q000188:drug therapy; D009349:Nematode Infections / Q000188:drug therapy; D010272:Parasitic Diseases / Q000188:drug therapy*; D012109:Research Support as Topic; D012552:Schistosomiasis / Q000188:drug therapy; D014123:Toxoplasmosis / Q000188:drug therapy; D014481:United States; D000078329:Workforce
D000871:Anthelmintics; D000890:Anti-Infective Agents; D000981:Antiprotozoal Agents